Seelos Therapeutics, Inc. (SEELQ)
OTCMKTS
· Delayed Price · Currency is USD
0.270
-0.020 (-6.90%)
Dec 20, 2024, 4:00 PM EST
Seelos Therapeutics Employees
As of December 31, 2023, Seelos Therapeutics had 16 total employees, including 15 full-time and 1 part-time employees. The number of employees did not change compared to the previous year.
Employees
16
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$251,750
Profits / Employee
$511,375
Market Cap
116.27K
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 16 | 0 | - |
| Dec 31, 2022 | 16 | 0 | - |
| Dec 31, 2021 | 16 | 6 | 60.00% |
| Dec 31, 2020 | 10 | 4 | 66.67% |
| Dec 31, 2019 | 6 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Sandoz Group AG | 22,633 |
| Telix Pharmaceuticals Limited | 234 |
| Elekta AB (publ) | 4,718 |
| Ryman Healthcare Limited | 7,700 |
| Verano Holdings Corp. | 3,900 |
| Vireo Growth Inc. | 490 |
| Medexus Pharmaceuticals Inc. | 82 |
Seelos Therapeutics News
- 2 months ago - Seelos Announces Second Postponement of its Annual Meeting of Stockholders - PRNewsWire
- 2 months ago - Seelos Therapeutics Announces Notice of Delisting from Nasdaq and Transfer of Listing to Over-the-Counter Market - PRNewsWire
- 3 months ago - Seelos Announces Postponement of its Annual Meeting of Stockholders - PRNewsWire
- 3 months ago - Seelos Therapeutics Announces 1-for-16 Reverse Stock Split - PRNewsWire
- 3 months ago - Seelos Therapeutics announces the signing of a Material Transfer Agreement with U.S. Army Medical Materiel Development Activity (USAMMDA) to evaluate SLS-002 for treatment of PTSD - PRNewsWire
- 7 months ago - Seelos Therapeutics Announces Pricing of $1.1 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules - PRNewsWire
- 7 months ago - Seelos Therapeutics Announces 1-for-8 Reverse Stock Split - PRNewsWire
- 8 months ago - Seelos Therapeutics Announces Strategic Focus on Mental Health Initiatives and Provides an Update on Current Discussions of Potential Partnerships and Collaborations - PRNewsWire